Acquisition of common stock by Morepen Bio, Inc., a Wholly Owned Subsidiary of the Company
As filed · Morepen Laboratories Limited has informed the Exchange about Acquisition of common stock by Morepen Bio, Inc., a Wholly Owned Subsidiary of the Company
M&AWatchMajormateriality 79 out of 100
What happened
FactMorepen Laboratories Limited has announced that its wholly owned subsidiary, Morepen Bio, Inc., has acquired 135,000 shares of common stock in ICB International, Inc. for a total amount of USD 675,000. The acquisition is effective as of March 1, 2025. The company received the intimation regarding this acquisition on March 31, 2025.
Why it matters
CapitSignal interpretationAn acquisition spends cash or issues shares today for earnings that arrive later, so the price paid and the funding route decide whether holders gain.
Watch next
Fact- Consideration and how it is funded
- Revenue and profit of the target
- Expected completion date
Evidence
How CapitSignal classified this
- Reasoning:
- ACQUISITION base 74; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%